结直肠癌肝转移患者不同保留肝实质肝切除术式的结局及瘤周影像特征的预后影响
回顾性纳入56例术前行动脉期钆塞酸二钠增强MRI的结直肠癌肝转移患者,比较解剖性切除(AR)与非解剖性切除(NAR)的结局;NAR组3年无肝复发生存率低于AR组(36.6% vs 78.6%,p=0.012),NAR组中瘤周早期强化与较差的无肝复发生存(HR=6.260,95%CI 2.322–16.876)和无复发生存(HR=2.516,95%CI 1.069–5.919)相关。
要点
- NAR组3年无肝复发生存率低于AR组(36.6% vs 78.6%,p=0.012)
- NAR组中瘤周早期强化与较差的无肝复发生存相关(HR=6.260,95%CI 2.322–16.876)
- NAR组中瘤周早期强化与较差的无复发生存相关(HR=2.516,95%CI 1.069–5.919)
核心结论
- 在按照保留肝实质原则行NAR的结直肠癌肝转移患者中,瘤周早期强化是无肝复发生存和无复发生存的预测因素。
研究设计与样本
- 回顾性研究,纳入56例术前行动脉期钆塞酸二钠增强MRI的结直肠癌肝转移患者,评估瘤周早期强化、肝胆期瘤周低信号和瘤周胆管扩张三个影像特征,采用Kaplan-Meier法计算生存并用多因素分析寻找独立预测因素。
关键影像表现/征象
- MRI上评估了瘤周早期强化、肝胆期瘤周低信号和朝向结直肠癌肝转移灶的胆管扩张三个瘤周影像特征。
临床应用与阅片要点
- 在按照保留肝实质原则行NAR的结直肠癌肝转移患者中,可关注术前MRI上的瘤周早期强化以提示无肝复发生存和无复发生存可能较差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Parenchymal-sparing hepatectomy (PSH) is recommended in patients with colorectal liver metastases (CRLM). Based on the principle of PSH, to investigate the impact of anatomical resection (AR) and non-anatomic resection (NAR) on the outcome of CRLM and to evaluate the potential prognostic impact of three peritumoral imaging features.
METHODS: Fifty-six patients who had abdominal gadoxetic acid-enhanced magnetic resonance imaging (MRI) before CRLM surgery were included in this retrospective research. Peritumoral early enhancement, peritumoral hypointensity on hepatobiliary phase (HBP), and biliary dilatation to the CRLM at MRI were evaluated. Survival estimates were calculated using the Kaplan-Meier method, and multivariate analysis was conducted to identify independent predictors of liver recurrence-free survival (LRFS), recurrence-free survival (RFS) and overall survival (OS).
RESULTS: NAR had a lower 3-year LRFS compared with AR (36.6% vs. 78.6%, p = 0.012). No significant differences were found in 3-year RFS (34.1% vs. 41.7%) and OS (61.7% vs. 81.3%) (p > 0.05). In NAR group, peritumoral early enhancement was associated with poor LRFS (p = < 0.001, hazard ratio [HR] = 6.260; 95% confidence interval [CI], 2.322,16.876]) and poor RFS (p = 0.035, HR =2.516; 95% CI, 1.069,5.919). No independent predictors of CRLM were identified in the AR group.
CONCLUSIONS: In patients with CRLM, peritumoral early enhancement was a predictor of LRFS and RFS after NAR according to the principle of PSH.
引用
- Liu L, Xie L, Zhou Y, et al. Outcomes of different parenchymal-sparing hepatectomies in patients with colorectal liver metastases and prognostic impact of peritumoral imaging features. Abdom Radiol (NY). 2023. PMID: 37750923. doi:10.1007/s00261-023-04044-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。